The Future of Cardiovascular-Kidney-Metabolic (CKM)- Direct to Participant Trials

• We must bring trials to the patient rather than the patient to the trials.
• We must democratize access to the trials.

Speakers:

C. Michael Gibson, MD

President & Chief Executive Officer

Baim Institute for Clinical Research